Singapore markets closed

TScan Therapeutics, Inc. (TCRX)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
7.68+0.36 (+4.92%)
At close: 04:00PM EDT
7.85 +0.17 (+2.21%)
After hours: 05:17PM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Assets
Current assets
Cash
Cash and cash equivalents
133,359
120,027
161,405
34,791
Other short-term investments
58,685
0
-
-
Total cash
192,044
120,027
161,405
34,791
Other current assets
2,193
4,100
4,249
-
Total current assets
194,237
124,127
165,654
36,445
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
85,831
79,422
22,339
14,287
Accumulated depreciation
-14,597
-10,220
-5,083
-1,755
Net property, plant and equipment
71,234
69,202
17,256
12,532
Other long-term assets
6,678
5,762
5,197
595
Total non-current assets
77,912
74,964
22,453
13,293
Total assets
272,149
199,091
188,107
49,738
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
3,347
-
-
-
Accounts payable
2,374
2,912
1,765
2,910
Accrued liabilities
4,813
2,050
2,905
827
Deferred revenues
10,137
3,874
11,410
10,627
Other current liabilities
425
431
1,012
132
Total current liabilities
29,820
17,305
21,343
17,446
Non-current liabilities
Long-term debt
26,700
29,290
-
-
Deferred revenues
5,622
0
1,497
8,816
Other long-term liabilities
-
49
97
238
Total non-current liabilities
91,462
82,352
5,986
74,754
Total liabilities
121,282
99,657
27,329
92,200
Stockholders' equity
Common stock
5
3
3
1
Retained earnings
-247,597
-158,379
-92,158
-43,533
Total stockholders' equity
150,867
99,434
160,778
-42,462
Total liabilities and stockholders' equity
272,149
199,091
188,107
49,738